Cytovale®, a commercial-stage medical diagnostics company, today celebrated a monumental year that catapulted it to lead the emerging sepsis diagnostics market, driven by increased demand for ...
Reflecting on his tenure, Pascal Behr, Ph.D., said, “I am proud of what we’ve achieved together and I am confident that Simon, with his strategic vision and deep industry expertise, is well-positioned ...
FlowBeams, creator of the BoldJet needle-free injection showcased itsbreakthrough medtech technology at CES 2025.The company’s innovative needle-free injection ...
Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of DirectorsZÜRICH, Switzerland, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Cytosurge AG, a leader in single-cell man ...